Who can expect to get the COVID-19 antiviral pill in B.C., and how many will be available?
There's another tool in the fight against COVID-19 and B.C.'s top doctor said it will help prevent more serious illness if it's given to people early on.
Health Canada authorized the use of Pfizer's COVID-19 antiviral treatment Paxlovid Monday, and it's the first oral and at-home prescription medication to be cleared for use in the country.
In a news conference Tuesday, Dr. Bonnie Henry said the antiviral treatment is designed specifically for individuals at the highest risk of developing more severe illness and ending up in hospital.
"It includes those people in our community who are over age 70, clinically extremely vulnerable, immune compromised and for younger people who have additional medical conditions and don’t have the protection of vaccines."
Henry said B.C. can expect a limited supply of 4,000 treatment doses within the next few weeks.
The prescription-only medication must be started within five days of the onset of symptoms.
Henry added that the province is working with its clinical care advisory team to distribute the treatment where it can be the most effective.
"This is very good news. It's not going to change the trajectory of our pandemic right now but it's another tool to help those people who are more at-risk of ending up in hospital," she said.
University of British Columbia associate professor and drug safety researcher Mahyar Etminan said the treatment should not be viewed as a magic bullet.
"We don’t really have any data on children or healthy adults," he said. "So primarily, it was studied in adults who had COVID symptoms and had one other medical condition."
Etminan said the efficacy numbers being shared by the company for the treatment also need to be put in perspective.
"Unfortunately, the way they presented the data is this relative risk reduction metric, which tends to sort of overestimate the efficacy," he said, and noted Pfizer has reported an 88 per cent reduction of either hospitalization or death relative to the placebo group.
"In absolute numbers, it’s about a six per cent benefit...if 16 such participants took the drugs, one would benefit."
Etminan said roughly a thousand adults were part of the Pfizer study that received the antiviral combination, which helps prevent the replication of COVID in the body. He said a similar number were given a placebo.
"It’s also important to know that the data we have is data provided by the company," he said. "We still don’t have any peer-reviewed data from this study."
Etminan said based on the available data, "it seems like it should really be intended for adults who are at a high-risk of morbidity or dying from COVID."
"It comes down to risk versus benefits," he said. "It seems from the data we have that that sort of demographic would, right now at least, benefit the most from this drug."
Two additional vaccines, Medicago and Novavax, continue to be under review by Health Canada.
"We were hoping (Novavax) would be approved sometime in January, but it looks like it's more likely to be in February and Medicago may be as early as the end of January or February," Henry said.
"So I think that's important for those people who have made that determination that the mRNA vaccines that we have, and are holding out for something else. It's not going to be available to help you through this wave. But it is an additional option that will be coming, we hope, in the near future."
CTVNews.ca Top Stories
RCMP uncovers plot to sell drones and equipment to Libya
The RCMP says it has uncovered a plot by two men in Montreal to sell Chinese drones and military equipment to Libya illegally.
Demonstrators kicked out of Ontario legislature for disruption after failed keffiyeh vote
A group of demonstrators were kicked out of the legislature after a second NDP motion calling for unanimous consent to reverse a ban on the keffiyeh failed to pass.
Tom Mulcair: Park littered with trash after 'pilot project' is perfect symbol of Trudeau governance
Former NDP leader Tom Mulcair says that what's happening now in a trash-littered federal park in Quebec is a perfect metaphor for how the Trudeau government runs things.
Man wanted in connection with deadly shooting in Toronto tops list of most wanted fugitives in Canada
A 35-year-old man wanted in connection with the murder of Toronto resident 29-year-old Sharmar Powell-Flowers nine months ago has topped the list of the BOLO program’s 25 most wanted fugitives across Canada, police announced Tuesday.
Doctors ask Liberal government to reconsider capital gains tax change
The Canadian Medical Association is asking the federal government to reconsider its proposed changes to capital gains taxation, arguing it will affect doctors' retirement savings.
Keeping these exotic pets is 'cruel' and 'dangerous,' Canadian animal advocates say
Canadian pet owners are finding companionship beyond dogs and cats. Tigers, alligators, scorpions and tarantulas are among some of the exotic pets they are keeping in private homes, which pose risks to public safety and animal welfare, advocates say.
Thieves use stolen forklift to rip cash machine out of U.K. bank
Police in the U.K. are searching for a group of suspects seen on video using a forklift to steal a cash machine from a bank.
'There was a lot of black smoke': Crane operator sounds alarm while trapped during highrise fire in Halifax
A tower crane operator alerted emergency crews after noticing a fire on a construction site in Halifax Tuesday morning.
Cherry blossoms blooming in Canada: Here's what to know
There is a swaying sea of colour in some cities across Canada, and it's a sure sign of spring: cherry blossoms are in bloom.